Open Access

Sinomenine attenuates airway inflammation and remodeling in a mouse model of asthma

  • Authors:
    • Hai‑Rong Bao
    • Xiao‑Ju Liu
    • Yun‑Lin Li
    • Xiang Men
    • Xiao‑Li Zeng
  • View Affiliations

  • Published online on: January 28, 2016     https://doi.org/10.3892/mmr.2016.4816
  • Pages: 2415-2422
  • Copyright: © Bao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Asthma is an inflammatory disease that involves airway inflammation and remodeling. Sinomenine (SIN) has been demonstrated to have immunosuppressive and anti‑inflammatory properties. The aim of the present study was to investigate the inhibitory effects of SIN on airway inflammation and remodeling in an asthma mouse model and observe the effects of SIN on the transforming growth factor‑β1 (TGF‑β1)/connective tissue growth factor (CTGF) pathway and oxidative stress. Female BALB/c mice were sensitized by repetitive ovalbumin (OVA) challenge for 6 weeks in order to develop a mouse model of asthma. OVA‑sensitized animals received SIN (25, 50 and 75 mg/kg) or dexamethasone (2 mg/kg). A blank control group received saline only. The area of smooth muscle and collagen, levels of mucus secretion and inflammatory cell infiltration were evaluated 24 h subsequent to the final OVA challenge. mRNA and protein levels of TGF‑β1 and CTGF were determined by reverse transcription‑quantitative polymerase chain reaction and immunohistology, respectively. The indicators of oxidative stress were detected by spectrophotometry. SIN significantly reduced allergen‑induced increases in smooth muscle thickness, mucous gland hypertrophy, goblet cell hyperplasia, collagen deposition and eosinophilic inflammation. The levels of TGF‑β1 and CTGF mRNA and protein were significantly reduced in the lungs of mice treated with SIN. Additionally, the total antioxidant capacity was increased in lungs following treatment with SIN. The malondialdehyde content and myeloperoxidase activities in the lungs from OVA‑sensitized mice were significantly inhibited by SIN. In conclusion, SIN may inhibit airway inflammation and remodeling in asthma mouse models, and may have therapeutic efficacy in the treatment of asthma.

References

1 

Manuyakorn W, Howarth PH and Holgate ST: Airway remodelling in asthma and novel therapy. Asian Pac J Allergy Immunol. 31:3–10. 2013.PubMed/NCBI

2 

Al-Muhsen S, Johnson JR and Hamid Q: Remodeling in asthma. J Allergy Clin Immunol. 128:451–462; quiz 463–464. 2011. View Article : Google Scholar : PubMed/NCBI

3 

Lederlin M, Ozier A, Montaudon M, Begueret H, Ousova O, Marthan R, Berger P and Laurent F: Airway remodeling in a mouse asthma model assessed by in-vivo respiratory-gated micro-computed tomography. Eur Radiol. 20:128–137. 2010. View Article : Google Scholar

4 

Kearley J, Buckland KF, Mathie SA and Lloyd CM: Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway. Am J Respir Crit Care Med. 179:772–781. 2009. View Article : Google Scholar : PubMed/NCBI

5 

King GG and Farah CS: Targeting airway remodelling in asthma: The how, what and where? Respirology. 17:585–587. 2012. View Article : Google Scholar : PubMed/NCBI

6 

Schmidt-Weber CB and Blaser K: The role of TGF-beta in allergic inflammation. Immunol Allergy Clin North Am. 26:233–244. 2006. View Article : Google Scholar : PubMed/NCBI

7 

Redington AE, Madden J, Frew AJ, Djukanovic R, Roche WR, Holgate ST and Howarth PH: Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. Am Respir Crit Care Med. 156:642–647. 1997. View Article : Google Scholar

8 

Vignola AM, Chanez P, Chiappara G, Merendino A, Pace E, Rizzo A, la Rocca AM, Bellia V, Bonsignore G and Bousquet J: Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med. 156:591–599. 1997. View Article : Google Scholar : PubMed/NCBI

9 

Grotendorst GR: Connective tissue growth factor: A mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev. 8:171–179. 1997. View Article : Google Scholar

10 

Frazier K, Williams S, Kothapalli D, Klapper H and Grotendorst GR: Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol. 107:404–411. 1996. View Article : Google Scholar : PubMed/NCBI

11 

Johnson PR, Burgess JK, Ge Q, Poniris M, Boustany S, Twigg SM and Black JL: Connective tissue growth factor induces extracellular matrix in asthmatic airway smooth muscle. Am J Respir Crit Care Med. 173:32–41. 2006. View Article : Google Scholar

12 

Sahiner UM, Birben E, Erzurum S, Sackesen C and Kalayci O: Oxidative stress in asthma. World Allergy Organ J. 4:151–158. 2011. View Article : Google Scholar : PubMed/NCBI

13 

Park CS, Kim TB, Lee KY, Moon KA, Bae YJ, Jang MK, Cho YS and Moon HB: Increased oxidative stress in the airway and development of allergic inflammation in a mouse model of asthma. Ann Allergy Asthma Immunol. 103:238–247. 2009. View Article : Google Scholar : PubMed/NCBI

14 

Baraket M, Oliver BG, Burgess JK, Lim S, King GG and Black JL: Is low dose inhaled corticosteroid therapy as effective for inflammation and remodeling in asthma? A randomized, parallel group study. Respir Res. 13:112012. View Article : Google Scholar : PubMed/NCBI

15 

Gao T, Hao J, Wiesenfeld-Hallin Z, Wang DQ and Xu XJ: Analgesic effect of sinomenine in rodents after inflammation and nerve injury. Eur J Pharmacol. 721:5–11. 2013. View Article : Google Scholar : PubMed/NCBI

16 

Wang Q and Li XK: Immunosuppressive and anti-inflammatory activities of sinomenine. Int Immunopharmacol. 11:373–376. 2011. View Article : Google Scholar

17 

Zhou H, Wong YF, Wang J, Cai X and Liu L: Sinomenine ameliorates arthritis via MMPs, TIMPs, and cytokines in rats. Biochem Biophys Res Commun. 376:352–357. 2008. View Article : Google Scholar : PubMed/NCBI

18 

Temelkovski J, Hogan SP, Shepherd DP, Foster PS and Kumar RK: An improved murine model of asthma: Selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax. 3:849–856. 1998. View Article : Google Scholar

19 

Duan W, Chan JH, Wong CH, Leung BP and Wong WS: Anti-inflammatory effects of mitogen-activated protein kinase kinase inhibitor U0126 in an asthma mouse model. J Immunol. 172:7053–7059. 2004. View Article : Google Scholar : PubMed/NCBI

20 

Weibel ER: Principles and methods for the morphometric study of the lung and other organs. Lab Invest. 12:131–155. 1963.PubMed/NCBI

21 

Angeli P, Prado CM, Xisto DG, Silva PL, Pássaro CP, Nakazato HD, Leick-Maldonado EA, Martins MA, Rocco PR and Tibério IF: Effects of chronic L-NAME treatment lung tissue mechanics, eosinophilic and extracellular matrix responses induced by chronic pulmonary inflammation. Am J Physiol Lung Cell Mol Physiol. 294:L1197–L1205. 2008. View Article : Google Scholar : PubMed/NCBI

22 

Henderson WR Jr, Tang LO, Chu SJ, Tsao SM, Chiang GK, Jones F, Jonas M, Pae C, Wang H and Chi EY: A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med. 165:108–116. 2002. View Article : Google Scholar : PubMed/NCBI

23 

Zhou L, Qian ZX, Li F and Liu RY: The effect of melatonin on the regulation of collagen accumulation and matrix metal-loproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 mRNA and protein in a murine model of chronic asthma. Zhonghua Jie He He Hu Xi Za Zhi. 30:527–532. 2007.In Chinese. PubMed/NCBI

24 

Toledo AC, Sakoda CP, Perini A, Pinheiro NM, Magalhães RM, Grecco S, Tibério IF, Câmara NO, Martins MA, Lago JH and Prado CM: Flavonone treatment reverses airway inflammation and remodelling in an asthma murine model. Br J Pharmacol. 168:1736–1749. 2013. View Article : Google Scholar :

25 

Oda H, Kawayama T, Imaoka H, Sakazaki Y, Kaku Y, Okamoto M, Kitasato Y, Edakuni N, Takenaka S, Yoshida M, et al: Interleukin-18 expression, CD8(+) T cells, and eosinophils in lungs of nonsmokers with fatal asthma. Ann Allergy Asthma Immunol. 112:23–28. 2014. View Article : Google Scholar

26 

Kok TW, Yue PY, Mak NK, Fan TP, Liu L and Wong RN: The anti-angiogenic effect of sinomenine. Angiogenesis. 8:3–12. 2005. View Article : Google Scholar : PubMed/NCBI

27 

Chen DP, Wong CK, Leung PC, Fung KP, Lau CB, Lau CP, Li EK, Tam LS and Lam CW: Anti-inflammatory activities of Chinese herbal medicine sinomenine and Liang Miao San on tumor necrosis factor-α-activated human fibroblast-like synoviocytes in rheumatoid arthritis. J Ethnopharmacol. 137:457–468. 2011. View Article : Google Scholar : PubMed/NCBI

28 

Busse WW and Lemanske RF Jr: Asthma. N Engl J Med. 344:350–362. 2001. View Article : Google Scholar : PubMed/NCBI

29 

Manuyakorn W: Airway remodelling in asthma: Role for mechanical forces. Asia Pac Allergy. 4:19–24. 2014. View Article : Google Scholar : PubMed/NCBI

30 

Holgate ST, Holloway J, Wilson S, Howarth PH, Haitchi HM, Babu S and Davies DE: Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities. J Allergy Clin Immunol. 117:496–506; quiz 507. 2006. View Article : Google Scholar : PubMed/NCBI

31 

Hardy CL, Nguyen HA, Mohamud R, Yao J, Oh DY, Plebanski M, Loveland KL, Harrison CA, Rolland JM and O'Hehir RE: The activin A antagonist follistatin inhibits asthmatic airway remodelling. Thorax. 68:9–18. 2013. View Article : Google Scholar

32 

Bowler RP and Crapo JD: Oxidative stress in allergic respiratory diseases. J Allergy Clin Immunol. 110:349–356. 2002. View Article : Google Scholar : PubMed/NCBI

33 

Sugiura H and Ichinose M: Oxidative and nitrative stress in bronchial asthma. Antioxid Redox Signal. 10:785–797. 2008. View Article : Google Scholar : PubMed/NCBI

34 

Brown SD, Baxter KM, Stephenson ST, Esper AM, Brown LA and Fitzpatrick AM: Airway TGF-β1 and oxidant stress in children with severe asthma: Association with airflow limitation. J Allergy Clin Immunol. 129:388–396. 2012. View Article : Google Scholar

35 

Fatani SH: Biomarkers of oxidative stress in acute and chronic bronchial asthma. J Asthma. 51:578–584. 2014. View Article : Google Scholar : PubMed/NCBI

36 

Ayala A, Muñoz MF and Argüelles S: Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014:360–438. 2014. View Article : Google Scholar

37 

Vignola AM, Riccobono L, Mirabella A, Profita M, Chanez P, Bellia V, Mautino G, D'accardi P, Bousquet J and Bonsignore G: Sputum metalloproteinase-9/tissue inhibitor of metallopro-teinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med. 158:1945–1950. 1998. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

March 2016
Volume 13 Issue 3

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Bao, H., Liu, X., Li, Y., Men, X., & Zeng, X. (2016). Sinomenine attenuates airway inflammation and remodeling in a mouse model of asthma. Molecular Medicine Reports, 13, 2415-2422. https://doi.org/10.3892/mmr.2016.4816
MLA
Bao, H., Liu, X., Li, Y., Men, X., Zeng, X."Sinomenine attenuates airway inflammation and remodeling in a mouse model of asthma". Molecular Medicine Reports 13.3 (2016): 2415-2422.
Chicago
Bao, H., Liu, X., Li, Y., Men, X., Zeng, X."Sinomenine attenuates airway inflammation and remodeling in a mouse model of asthma". Molecular Medicine Reports 13, no. 3 (2016): 2415-2422. https://doi.org/10.3892/mmr.2016.4816